Rule 10b-5
Rule 10b-5 is the SEC's primary anti-fraud rule under the Securities Exchange Act of 1934, prohibiting any person from making false statements, omitting material facts, or engaging in any scheme to defraud in connection with the purchase or sale of any security.
Rule 10b-5 was promulgated by the SEC in 1942 under the authority granted by Section 10(b) of the Securities Exchange Act of 1934. Despite its brief text, it has become the most litigated provision in U.S. securities law and serves as the legal foundation for a vast range of enforcement actions and private lawsuits involving securities fraud. The rule makes it unlawful for any person, directly or indirectly, to employ any device or scheme to defraud, to make any untrue statement of a material fact, to omit a material fact necessary to make statements not misleading, or to engage in any act that operates as a fraud or deceit in connection with the purchase or sale of any security.
The reach of Rule 10b-5 is deliberately broad. It applies to virtually any market participant — corporations, executives, brokers, financial advisers, hedge fund managers, and private individuals — and covers both the purchase and sale side of any securities transaction. Both the SEC (in civil enforcement actions) and the Department of Justice (in criminal prosecutions) rely on Section 10(b) and Rule 10b-5, and private plaintiffs can also sue for damages under a judicially implied private right of action recognized by the Supreme Court.
For private securities fraud lawsuits under Rule 10b-5, plaintiffs must typically establish six elements: a material misstatement or omission, scienter (intentional or reckless conduct), a connection to the purchase or sale of a security, reliance by the plaintiff, economic loss, and loss causation. The Private Securities Litigation Reform Act of 1995 (PSLRA) raised the pleading standards for such lawsuits, requiring plaintiffs to plead specific facts supporting a strong inference of scienter and to specify the allegedly misleading statements, before discovery can proceed.
Insider trading cases are predominantly brought under Rule 10b-5 using the classical theory (corporate insiders trading on MNPI in breach of a duty to shareholders) or the misappropriation theory (outsiders trading on information misappropriated from a source to whom they owed a duty of trust). Market manipulation cases — such as pump-and-dump schemes, wash trading, and spoofing — are also prosecuted under Rule 10b-5 as schemes to defraud.
For public companies, Rule 10b-5 imposes ongoing obligations to avoid making materially misleading statements in press releases, earnings calls, SEC filings, and investor presentations. A common defense is the safe harbor for forward-looking statements established by the PSLRA, which protects projections and forecasts accompanied by meaningful cautionary language identifying specific risk factors that could cause actual results to differ.